In addition, it was also reported that the pharmacological effect of MET inhibitors on the growth of cancer cells was attenuated under HGF-rich condition, and additional inhibition of inhibitor of HGF-activating proteases overcame the resistance [30]. The gene discussed is HGF; the disease is cancer.